Orai1-STIM1 Regulates Increased Ca2+ Mobilization, Leading to Contractile Duchenne Muscular Dystrophy Phenotypes in Patient-Derived Induced Pluripotent Stem Cells

Ca2+ overload is one of the factors leading to Duchenne muscular dystrophy (DMD) pathogenesis. However, the molecular targets of dystrophin deficiency-dependent Ca2+ overload and the correlation between Ca2+ overload and contractile DMD phenotypes in in vitro human models remain largely elusive. In this study, we utilized DMD patient-derived induced pluripotent stem cells (iPSCs) to differentiate myotubes using doxycycline-inducible MyoD overexpression, and searched for a target molecule that mediates dystrophin deficiency-dependent Ca2+ overload using commercially available chemicals and siRNAs. We found that several store-operated Ca2+ channel (SOC) inhibitors effectively prevented Ca2+ overload and identified that STIM1-Orai1 is a molecular target of SOCs. These findings were further confirmed by demonstrating that STIM1-Orai1 inhibitors, CM4620, AnCoA4, and GSK797A, prevented Ca2+ overload in dystrophic myotubes. Finally, we evaluated CM4620, AnCoA4, and GSK7975A activities using a previously reported model recapitulating a muscle fatigue-like decline in contractile performance in DMD. All three chemicals ameliorated the decline in contractile performance, indicating that modulating STIM1-Orai1-mediated Ca2+ overload is effective in rescuing contractile phenotypes. In conclusion, SOCs are major contributors to dystrophin deficiency-dependent Ca2+ overload through STIM1-Orai1 as molecular mediators. Modulating STIM1-Orai1 activity was effective in ameliorating the decline in contractile performance in DMD.

Automated summary

The study showed that STIM1-Orai1 is a molecular target of store-operated Ca2+ channels (SOCs) and modulating its activity effectively ameliorated the decline in contractile performance in DMD.SOCs play a major role in causing dystrophin deficiency-dependent Ca2+ overload, and targeting STIM1-Orai1-mediated Ca2+ overload is an effective approach to rescuing contractile phenotypes in DMD.